• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

解析血管紧张素 II 型 1 受体与 Gα 和 β-arrestin 偶联的变构机制。

Unraveling allostery within the angiotensin II type 1 receptor for Gα and β-arrestin coupling.

机构信息

Department of Pharmacology and Therapeutics, McGill University, Montréal, Québec H3G 1Y6, Canada.

Department of Computational and Quantitative Medicine, Beckman Research Institute of the City of Hope, Duarte, CA 91010, USA.

出版信息

Sci Signal. 2023 Aug 8;16(797):eadf2173. doi: 10.1126/scisignal.adf2173.

DOI:10.1126/scisignal.adf2173
PMID:37552769
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10640921/
Abstract

G protein-coupled receptors engage both G proteins and β-arrestins, and their coupling can be biased by ligands and mutations. Here, to resolve structural elements and mechanisms underlying effector coupling to the angiotensin II (AngII) type 1 receptor (AT1R), we combined alanine scanning mutagenesis of the entire sequence of the receptor with pharmacological profiling of Gα and β-arrestin engagement to mutant receptors and molecular dynamics simulations. We showed that Gα coupling to AT1R involved a large number of residues spread across the receptor, whereas fewer structural regions of the receptor contributed to β-arrestin coupling regulation. Residue stretches in transmembrane domain 4 conferred β-arrestin bias and represented an important structural element in AT1R for functional selectivity. Furthermore, we identified allosteric small-molecule binding sites that were enclosed by communities of residues that produced biased signaling when mutated. Last, we showed that allosteric communication within AT1R emanating from the Gα coupling site spread beyond the orthosteric AngII-binding site and across different regions of the receptor, including currently unresolved structural regions. Our findings reveal structural elements and mechanisms within AT1R that bias Gα and β-arrestin coupling and that could be harnessed to design biased receptors for research purposes and to develop allosteric modulators.

摘要

G 蛋白偶联受体与 G 蛋白和β-arrestin 结合,其配体和突变可使其偶联偏向化。在这里,为了解决效应器与血管紧张素 II (AngII) 1 型受体 (AT1R) 偶联的结构元件和机制,我们结合了受体整个序列的丙氨酸扫描突变与 Gα 和β-arrestin 与突变受体的结合以及分子动力学模拟的药理学分析。我们表明,Gα 与 AT1R 的偶联涉及受体上分布的大量残基,而受体的较少结构区域有助于β-arrestin 偶联调节。跨膜域 4 中的残基延伸赋予了β-arrestin 偏向性,并且是 AT1R 中功能性选择性的重要结构元件。此外,我们确定了变构小分子结合位点,这些位点被产生偏向信号的残基社区包围。最后,我们表明,源自 Gα 偶联位点的 AT1R 内的变构通讯不仅在 AT1R 的变构 AngII 结合位点之外传播,而且跨越了受体的不同区域,包括目前尚未解决的结构区域。我们的发现揭示了 AT1R 内偏向 Gα 和β-arrestin 偶联的结构元件和机制,这些元件和机制可用于设计用于研究目的的偏向性受体,并开发变构调节剂。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a8f/10640921/f47026dd89de/nihms-1933204-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a8f/10640921/c4a8bfd25edf/nihms-1933204-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a8f/10640921/2a50817f6786/nihms-1933204-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a8f/10640921/9761ed5145d3/nihms-1933204-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a8f/10640921/cbc36ce08c9b/nihms-1933204-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a8f/10640921/f47026dd89de/nihms-1933204-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a8f/10640921/c4a8bfd25edf/nihms-1933204-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a8f/10640921/2a50817f6786/nihms-1933204-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a8f/10640921/9761ed5145d3/nihms-1933204-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a8f/10640921/cbc36ce08c9b/nihms-1933204-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a8f/10640921/f47026dd89de/nihms-1933204-f0005.jpg

相似文献

1
Unraveling allostery within the angiotensin II type 1 receptor for Gα and β-arrestin coupling.解析血管紧张素 II 型 1 受体与 Gα 和 β-arrestin 偶联的变构机制。
Sci Signal. 2023 Aug 8;16(797):eadf2173. doi: 10.1126/scisignal.adf2173.
2
Loss of biased signaling at a G protein-coupled receptor in overexpressed systems.在过表达系统中,G 蛋白偶联受体的偏向信号丧失。
PLoS One. 2023 Mar 24;18(3):e0283477. doi: 10.1371/journal.pone.0283477. eCollection 2023.
3
Functional selectivity profiling of the angiotensin II type 1 receptor using pathway-wide BRET signaling sensors.利用通路范围 BRET 信号传感器对血管紧张素 II 型 1 受体进行功能选择性分析。
Sci Signal. 2018 Dec 4;11(559):eaat1631. doi: 10.1126/scisignal.aat1631.
4
Allosteric modulation of β-arrestin-biased angiotensin II type 1 receptor signaling by membrane stretch.膜拉伸对β-抑制蛋白偏向性血管紧张素II 1型受体信号传导的变构调节。
J Biol Chem. 2014 Oct 10;289(41):28271-83. doi: 10.1074/jbc.M114.585067. Epub 2014 Aug 28.
5
Angiotensin II type 1 receptor variants alter endosomal receptor-β-arrestin complex stability and MAPK activation.血管紧张素 II 型 1 型受体变体改变内体受体-β-arrestin 复合物的稳定性和 MAPK 激活。
J Biol Chem. 2020 Sep 18;295(38):13169-13180. doi: 10.1074/jbc.RA120.014330. Epub 2020 Jul 23.
6
Mechanoactivation of the angiotensin II type 1 receptor induces β-arrestin-biased signaling through Gα coupling.机械激活血管紧张素 II 型 1 受体通过 Gα 偶联诱导β-arrestin 偏向性信号转导。
J Cell Biochem. 2018 Apr;119(4):3586-3597. doi: 10.1002/jcb.26552. Epub 2018 Jan 4.
7
Genetic code expansion and photocross-linking identify different β-arrestin binding modes to the angiotensin II type 1 receptor.遗传密码扩展和光交联鉴定血管紧张素 II 型 1 受体与不同β-抑制蛋白结合模式。
J Biol Chem. 2019 Nov 15;294(46):17409-17420. doi: 10.1074/jbc.RA119.010324. Epub 2019 Sep 17.
8
Angiotensin type 1A receptor regulates β-arrestin binding of the β-adrenergic receptor via heterodimerization.1A型血管紧张素受体通过异源二聚化调节β-肾上腺素能受体的β-抑制蛋白结合。
Mol Cell Endocrinol. 2017 Feb 15;442:113-124. doi: 10.1016/j.mce.2016.11.027. Epub 2016 Nov 28.
9
Biased agonists differentially modulate the receptor conformation ensembles in Angiotensin II type 1 receptor.偏倚激动剂在血管紧张素 II 型 1 受体中差异调节受体构象集合。
J Mol Graph Model. 2023 Jan;118:108365. doi: 10.1016/j.jmgm.2022.108365. Epub 2022 Oct 20.
10
Adrenal angiotensin II type 1 receptor biased signaling: The case for "biased" inverse agonism for effective aldosterone suppression.肾上腺血管紧张素II 1型受体偏向性信号传导:“偏向性”反向激动作用实现有效醛固酮抑制的实例
Cell Signal. 2021 Jun;82:109967. doi: 10.1016/j.cellsig.2021.109967. Epub 2021 Feb 25.

引用本文的文献

1
Protein Frustration Reveals Active Sites in Co-Evolved GPCR:G Protein Complexes and in Engineered Targeted Degrader Complexes.蛋白质构象受挫揭示了共同进化的G蛋白偶联受体(GPCR):G蛋白复合物以及工程化靶向降解复合物中的活性位点。
bioRxiv. 2025 Jun 28:2025.06.27.660602. doi: 10.1101/2025.06.27.660602.
2
ProGuide: a flexible framework for modeling global conformational rearrangements in proteins using DEER-derived distance restraints.ProGuide:一个使用DEER衍生距离约束对蛋白质全局构象重排进行建模的灵活框架。
bioRxiv. 2025 Jun 8:2025.06.05.658127. doi: 10.1101/2025.06.05.658127.
3
Multiple intramolecular triggers converge to preferential G protein coupling in the CBR.

本文引用的文献

1
Structural insights into angiotensin receptor signaling modulation by balanced and biased agonists.平衡激动剂和偏激动剂对血管紧张素受体信号转导调节的结构见解。
EMBO J. 2023 Jun 1;42(11):e112940. doi: 10.15252/embj.2022112940. Epub 2023 Apr 11.
2
Structural and dynamic insights into supra-physiological activation and allosteric modulation of a muscarinic acetylcholine receptor.结构与动力学研究揭示了一种毒蕈碱型乙酰胆碱受体的超生理激活与变构调节机制。
Nat Commun. 2023 Jan 23;14(1):376. doi: 10.1038/s41467-022-35726-z.
3
Pathophysiology and pharmacology of G protein-coupled receptors in the heart.
多种分子内触发因素汇聚,导致CBR中优先的G蛋白偶联。
Nat Commun. 2025 Jun 11;16(1):5265. doi: 10.1038/s41467-025-60003-0.
4
Allosteric communication mechanism in the glucagon receptor.胰高血糖素受体中的变构通讯机制。
J Biol Chem. 2025 Apr 23;301(6):108530. doi: 10.1016/j.jbc.2025.108530.
5
Sturge-Weber syndrome: updates in translational neurology.斯特奇-韦伯综合征:转化神经学的进展
Front Neurol. 2024 Dec 2;15:1493873. doi: 10.3389/fneur.2024.1493873. eCollection 2024.
6
BaNDyT: Bayesian Network modeling of molecular Dynamics Trajectories.BaNDyT:分子动力学轨迹的贝叶斯网络建模
bioRxiv. 2024 Nov 8:2024.11.06.622318. doi: 10.1101/2024.11.06.622318.
7
Location-biased β-arrestin conformations direct GPCR signaling.定位偏向性β-抑制蛋白构象指导G蛋白偶联受体信号传导。
bioRxiv. 2024 Sep 26:2024.09.24.614742. doi: 10.1101/2024.09.24.614742.
8
Nanobody-Mediated Dualsteric Engagement of the Angiotensin Receptor Broadens Biased Ligand Pharmacology.纳米抗体介导的血管紧张素受体双位结合拓宽了偏向配体的药理学。
Mol Pharmacol. 2024 Feb 15;105(3):260-271. doi: 10.1124/molpharm.123.000797.
9
How New Developments in Pharmacology Receptor Theory Are Changing (Our Understanding of) Hypertension Therapy.药理学受体理论的新进展如何改变(我们对)高血压治疗的理解。
Am J Hypertens. 2024 Mar 15;37(4):248-260. doi: 10.1093/ajh/hpad121.
10
Ligand recognition and G-protein coupling of trace amine receptor TAAR1.痕量胺受体 TAAR1 的配体识别和 G 蛋白偶联。
Nature. 2023 Dec;624(7992):672-681. doi: 10.1038/s41586-023-06804-z. Epub 2023 Nov 7.
心脏中 G 蛋白偶联受体的病理生理学和药理学。
Cardiovasc Res. 2023 May 22;119(5):1117-1129. doi: 10.1093/cvr/cvac171.
4
Dynamic spatiotemporal determinants modulate GPCR:G protein coupling selectivity and promiscuity.动态时空决定因素调节 GPCR:G 蛋白偶联的选择性和混杂性。
Nat Commun. 2022 Dec 2;13(1):7428. doi: 10.1038/s41467-022-34055-5.
5
Prostaglandin F2α and angiotensin II type 1 receptors exhibit differential cognate G protein coupling regulation.前列腺素 F2α 和血管紧张素 II 型 1 受体表现出不同的同源 G 蛋白偶联调节。
J Biol Chem. 2022 Sep;298(9):102294. doi: 10.1016/j.jbc.2022.102294. Epub 2022 Jul 21.
6
Effector membrane translocation biosensors reveal G protein and βarrestin coupling profiles of 100 therapeutically relevant GPCRs.效应膜转位生物传感器揭示了 100 种治疗相关 GPCR 的 G 蛋白和β抑制蛋白偶联特征。
Elife. 2022 Mar 18;11:e74101. doi: 10.7554/eLife.74101.
7
GPCR kinase knockout cells reveal the impact of individual GRKs on arrestin binding and GPCR regulation.GPCR 激酶敲除细胞揭示了单个 GRKs 对抑制蛋白结合和 GPCR 调节的影响。
Nat Commun. 2022 Jan 27;13(1):540. doi: 10.1038/s41467-022-28152-8.
8
Heterotrimeric Gq proteins act as a switch for GRK5/6 selectivity underlying β-arrestin transducer bias.三聚体 Gq 蛋白作为 GRK5/6 选择性的开关,为β-arrestin 转导蛋白的偏向性提供基础。
Nat Commun. 2022 Jan 25;13(1):487. doi: 10.1038/s41467-022-28056-7.
9
Sequence coevolution and structure stabilization modulate olfactory receptor expression.序列共进化和结构稳定调控嗅觉受体表达。
Biophys J. 2022 Mar 1;121(5):830-840. doi: 10.1016/j.bpj.2022.01.015. Epub 2022 Jan 20.
10
Activation pathway of a G protein-coupled receptor uncovers conformational intermediates as targets for allosteric drug design.G 蛋白偶联受体的激活途径揭示了构象中间态可作为变构药物设计的靶点。
Nat Commun. 2021 Aug 5;12(1):4721. doi: 10.1038/s41467-021-25020-9.